Explore evidence

11 %HIV-1 RNA was detected before, during and after GUD in cervical secretions from four (11%), one (3%) and six (17%) women, respectively.

Kenyagenital ulcer disease (GUD) · VIH/sidapublished 2011Sexually transmitted infectionseurope_pmcdocument of 4 observationsDOI 10.1136/sti.2010.045369

401 personsIn a randomized trial of 401 persons with HIV with unhealthy alcohol use and risk for viral non-suppression, a brief alcohol intervention reduced unhealthy alcohol use but did not affect viral suppression at 24 weeks.

KenyaVIH/sidapublished 2023Journal of the International AIDS SocietyPubMed

22 patientsTwenty-two patients had non-nucleoside reverse transcriptase inhibitor resistance mutations, including G190A, K103N, V106A, Y181C, A98G, and Y188L.

KenyaVIH/sidapublished 2022MedicinePubMeddocument of 7 observations

38.2 %Of the RT drug-resistant mutations, 13 (38.2%) were seen in RNA only, 6 (17.6%) in DNA only, and 15 (44.1%) in both.

KenyaVIH/sidapublished 2007Journal of clinical microbiologyeurope_pmcdocument of 4 observations

86 infantsAmong 187 mother-infant pairs with postpartum data, 86 (46%) infants were HIV-exposed, uninfected (CHEU) and 101 (54%) were HIV-unexposed, uninfected (CHUU).

KenyaVIH/sidapublished 2025BMJ global healthPubMeddocument of 10 observations

24 %Twenty-four percent of enrolled women were HIV positive.

KenyaVIH/sidapublished 2022The American journal of tropical medicine and hygienePubMeddocument of 8 observations

57.2 %Among 208 HIV-infected ART-naïve adults in Kenya, 119 (57.2%) had no hepatitis B virus (HBV) markers.

Kenyahépatite B · VIH/sidapublished 2021PloS onePubMeddocument of 7 observations

4,400 children/youthThe target enrolment for the cross-sectional cohort is 4400 children/youth (4000 HIV-exposed uninfected and 400 HIV-unexposed uninfected).

KenyaVIH/sidapublished 2024BMJ openPubMeddocument of 4 observations

79 %In the SEARCH Study in rural Kenya and Uganda (2013–2017), 79% of HIV-positive persons had viral suppression at year 3 according to fully adjusted estimates.

KenyaVIH/sidaobserved 2013-2017published 2020Epidemiology (Cambridge, Mass.)PubMeddocument of 8 observations

16.3 %38 (16.3%) patients had suboptimal nevirapine plasma levels of <3400 ng/mL.

KenyaVIH/sidapublished 2022MedicinePubMeddocument of 7 observations

9.1 %In 1990, 9.1% of 10,000-person communities in western Kenya were HIV prevalence outliers.

KenyaVIH/sidaobserved 1990published 2025PLoS computational biologyPubMeddocument of 2 observations

16,017 non-responsesAmong 299 pregnant women living with HIV in Kenya, there were 16,017 (51%) instances of non-response to interactive text messages during the intervention period.

KenyaVIH/sidapublished 2024BMC pregnancy and childbirthPubMeddocument of 6 observations

4.4 %VMMC uptake in the combined interpersonal communication and dedicated service outlets arm was 4.4%.

KenyaVIH/sidapublished 2023PloS onePubMeddocument of 7 observations

15.4 %In the APS+HIVST arm, 15.4% (326/2111) of tested partners received provider-delivered HIV testing.

KenyaVIH/sidaobserved 2021published 2024Journal of the International AIDS SocietyPubMeddocument of 15 observations

460,758 peopleA total of 460,758 (57.4%) people living with HIV initiated antiretroviral therapy.

KenyaVIH/sidapublished 2020PloS onePubMeddocument of 12 observations

22 %The overall prevalence of HIV was 22% among women with vaginal discharge in Nairobi, Kenya.

KenyaVIH/sidaobserved 1997published 2000Sexually transmitted infectionseurope_pmcdocument of 9 observations

3.6 %Among young females who do not sell sex (YFNS) in Mombasa, Kenya, 3.6% were living with HIV.

KenyaVIH/sidaobserved 2015published 2020Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 11 observations

49 %By 2018, the estimated percentage of adolescent girls and young women who would know their HIV status was 49% if none were DREAMS invitees in uMkhanyakude, South Africa.

KenyaVIH/sidaobserved 2018published 2022AIDS (London, England)PubMeddocument of 11 observations

-1,124 USDBetter management was associated with lower unit costs for antiretroviral therapy (ART) of $-1,124.

KenyaVIH/sidapublished 2025PloS onePubMeddocument of 8 observations

1.43 aRRAntiretroviral therapy initiation among adolescents and young adults living with HIV aged 20–24 years was associated with a 43% higher adjusted risk ratio of viral suppression compared to initiation before age 10.

KenyaVIH/sidapublished 2022The Journal of the Association of Nurses in AIDS Care : JANACPubMeddocument of 5 observations

0.35 per_100_person_yearsHIV incidence was 0.35 per 100 person-years among PrEP initiators over 7,150 person-years of follow-up.

KenyaVIH/sidapublished 2021PLoS medicinePubMeddocument of 12 observations

40 %Participants at baseline were HIV-positive (40%).

KenyaVIH/sidapublished 2024VirusesPubMeddocument of 6 observations

14 %In Kenya, MTCT infection rates were at 14% by the end of 2015.

KenyaVIH/sidaobserved 2015published 2020African Journal of Health SciencesOpenAlexdocument of 9 observations

87.9 %At 6 months postpartum, HIV-free survival was 87.9% for children of women living with HIV who were lost to follow-up (LW) and 98.7% for children of women retained in care (RW).

KenyaVIH/sidapublished 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 13 observations

7 %Of the 207 randomly selected charts of adolescents living with HIV aged 15–19 years in Kiambu and Nakuru Counties, Kenya, 7% (n = 14) of viral load results were missing from the clinic electronic medical record.

KenyaVIH/sidapublished 2025The Journal of the Association of Nurses in AIDS Care : JANACPubMeddocument of 4 observations